3.beta.-[(Methoxalyl)oxy]-2.alpha.-(3-oxo-1-octeny l)-5-oxo-1.be

Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D31708

Patent

active

040051064

ABSTRACT:
Racemic or optically-active prostaglandin E.sub.1 is synthesized from racemic or optically-active precursors in good yield at the various steps from 3.alpha.,6,7,7.alpha.-tetrahydro-4-methyl-2-oxo-1.beta.-indaneheptanoic acid methyl ester proceeding through 2.alpha.-(2-carboxyethyl)-3.beta.-hydroxy-5-oxo-1.beta.-cyclopentaneheptan oic acid methyl ester, .delta.-lactone, 5-cyclic ethylene acetal, 2.alpha.-(2-carboxy-2-formylethyl)-3.beta.-hydroxy-5-oxo-1.beta.-cyclopent aneheptanoic acid methyl ester, .delta.-lactone, 5-cyclic ethylene acetal, 2.alpha.-(2-carboxy-2-oxoetyl)-3.beta.-hydroxy-5-oxo-1.beta.-cyclopentaneh eptanoic acid methyl ester, .delta.-lactone, 5-cyclic ethylene acetal, and 3.beta.-hydroxy-2.alpha.-(3-oxo-1-octenyl)-5-oxo-1.beta.-cyclopentanehepta noic acid methyl ester, 5-cyclic ethylene acetal.

REFERENCES:
patent: 3890351 (1975-06-01), Taub
patent: 3899525 (1975-08-01), Oda et al.
Taub et al, Chemical Communications, pp. 1258-1259, 1970.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3.beta.-[(Methoxalyl)oxy]-2.alpha.-(3-oxo-1-octeny l)-5-oxo-1.be does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3.beta.-[(Methoxalyl)oxy]-2.alpha.-(3-oxo-1-octeny l)-5-oxo-1.be, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3.beta.-[(Methoxalyl)oxy]-2.alpha.-(3-oxo-1-octeny l)-5-oxo-1.be will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1478425

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.